Science Board to the Food and Drug Administration; Notice of Meeting, 61293 [05-21036]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 203 / Friday, October 21, 2005 / Notices
Centers for Medicare and Medicaid
Services, Office of Strategic Operations
and Regulatory Affairs, Room C4–26–05,
7500 Security Boulevard, Baltimore, MD
21244–1850, Fax Number: (410) 786–
5267, Attn: William N. Parham, III and,
OMB Human Resources and Housing
Branch, Attention: CMS Desk Officer,
New Executive Office Building, Room
10235, Washington, DC 20503.
Dated: October 17, 2005.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. 05–21101 Filed 10–20–05; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Science Board to the Food and Drug
Administration; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Science Board to
FDA.
General Function of the Committee:
The Board shall provide advice
primarily to the agency’s Senior Science
Advisor and, as needed, to the
Commissioner of Food and Drugs and
other appropriate officials on specific
complex and technical issues as well as
emerging issues within the scientific
community in industry and academia.
Additionally, the Board will provide
advice to the agency on keeping pace
with technical and scientific evolutions
in the fields of regulatory science, on
formulating an appropriate research
agenda, and on upgrading its scientific
and research facilities to keep pace with
these changes. It will also provide the
means for critical review of agencysponsored intramural and extramural
scientific research programs.
Date and Time: The meeting will be
held on November 4, 2005, from 8:30
a.m. to 4 p.m.
Location: Washington Room, Holiday
Inn Bethesda, 8120 Wisconsin Ave.,
Bethesda, MD.
Contact Person: Jan Johannessen,
Office of the Commissioner (HF–33),
Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,
301–827–6687, jjohannessen@fda.gov,
VerDate Aug<31>2005
15:13 Oct 20, 2005
Jkt 208001
or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area), code 3014512603. Please call the
Information Line for up-to-date
information on this meeting.
Agenda: The Science Board will hear
about and discuss the following topics:
(1) An update on activities of the Drug
Safety Oversight Board, (2) the agency’s
Bioresearch Monitoring Initiative, and
(3) the Board’s science peer review
activities, including presentation of the
Board’s peer review of the Office of
Regulatory Affairs’ pesticide monitoring
program.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person by October 28, 2005. Oral
presentations from the public will be
scheduled between approximately 12:30
p.m. and 1:30 p.m. Time allotted for
each presentation may be limited. Those
desiring to make formal oral
presentations should notify the contact
person before October 28, 2005, and
submit a brief statement of the general
nature of the evidence or arguments
they wish to present, the names and
addresses of proposed participants, and
an indication of the approximate time
requested to make their presentation.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Jan
Johannessen at least 7 days in advance
of the meeting.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: October 14, 2005.
Jason Brodsky,
Acting Associate Commissioner for External
Relations.
[FR Doc. 05–21036 Filed 10–20–05; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
61293
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Statement of Organization, Functions
and Delegations of Authority
This notice amends Part R of the
Statement of Organization Functions
and Delegations of Authority of the
Department of Health and Human
Services (HHS), Health Resources and
Services Administration (HRSA) as
amended at (60 FR 56605, November 6,
1995; amended at 67 FR 46519, July 15,
2002; 68 FR 787–793, January 7, 2003,
and 68 FR 64357–64358, November 13,
2003; and last amended at 69 FR 56433–
56434, September 21, 2004).
This notice reflects changes to the
organization and functions of the Office
of Communications (RA6) and the
Office of Information Technology (RAG)
both in the Office of the Administrator
(RA): Specifically, it moves the Audio
Visual technology support function
from the Office of Information
Technology to the Office of
Communications.
Chapter RA—Office of the
Administrator
Section RA–10, Organization
The Office of the Administrator (OA)
is headed by the Administrator, Health
Resources and Services Administration,
who reports directly to the Secretary.
The OA includes the following
components:
(1) Immediate Office of the
Administrator (RA);
(2) Office of Equal Opportunity and
Civil Rights (RA2);
(3) Office of Planning and Evaluation
(RA5);
(4) Office of Communications (RA6);
(5) Office of Minority Health and
Health Disparities (RA9);
(6) Office of Legislation (RAE);
(7) Office of International Health
Affairs (RAH); and
(8) Office of Information Technology
(RAG).
Section RA–20, Functions
Delete the functional statements for
the Office of Communications (RA6)
and the Office of Information
Technology (RAG) in their entirety and
replace it with the following:
Office of Communication (RA6)
Provides leadership and general
policy and program direction for, and
conducts and coordinates
communications and public affairs
activities of the Agency; Specifically, (1)
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 70, Number 203 (Friday, October 21, 2005)]
[Notices]
[Page 61293]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-21036]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Science Board to the Food and Drug Administration; Notice of
Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Science Board to FDA.
General Function of the Committee: The Board shall provide advice
primarily to the agency's Senior Science Advisor and, as needed, to the
Commissioner of Food and Drugs and other appropriate officials on
specific complex and technical issues as well as emerging issues within
the scientific community in industry and academia. Additionally, the
Board will provide advice to the agency on keeping pace with technical
and scientific evolutions in the fields of regulatory science, on
formulating an appropriate research agenda, and on upgrading its
scientific and research facilities to keep pace with these changes. It
will also provide the means for critical review of agency-sponsored
intramural and extramural scientific research programs.
Date and Time: The meeting will be held on November 4, 2005, from
8:30 a.m. to 4 p.m.
Location: Washington Room, Holiday Inn Bethesda, 8120 Wisconsin
Ave., Bethesda, MD.
Contact Person: Jan Johannessen, Office of the Commissioner (HF-
33), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD
20857, 301-827-6687, jjohannessen@fda.gov, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code 3014512603. Please call the Information Line for up-to-date
information on this meeting.
Agenda: The Science Board will hear about and discuss the following
topics: (1) An update on activities of the Drug Safety Oversight Board,
(2) the agency's Bioresearch Monitoring Initiative, and (3) the Board's
science peer review activities, including presentation of the Board's
peer review of the Office of Regulatory Affairs' pesticide monitoring
program.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by October 28,
2005. Oral presentations from the public will be scheduled between
approximately 12:30 p.m. and 1:30 p.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before October 28, 2005,
and submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Jan Johannessen at
least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: October 14, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. 05-21036 Filed 10-20-05; 8:45 am]
BILLING CODE 4160-01-S
